Staff Profiles
|
Dana P. GoldmanSanta Monica Office Affiliated Adjunct Staff Media AvailabilityThis researcher is available for interviews. Show Details » EducationPh.D. in economics, Stanford University; B.A. in economics, Cornell University |
Biography
Dana P. Goldman was the founding director of the Bing Center for Health Economics at RAND. Heis also the director of the RAND Roybal Center for Health Policy Simulation, which is designed to provide better estimates of the effects of health policy changes. His research interests combine applied microeconomics and medical issues, with a special interest in the role that medical technology and health insurance play in determining health-related outcomes.
Research Focus
Economics of chronic disease; health care reform; health care organization, economics, and finance; pharmaceutical regulation and innovation; pharmacy benefit design
RAND Research Areas
Recent Projects
- Roybal Center for Health Policy Simulation sponsored by National Institute of Aging, 2004-2009
- Understanding How Cost-Sharing Affects Use of Specialty Drugs sponsored by Genentech, 2006-2007
- Education, Self-Management, and Adherence sponsored by National Institute of Aging, 2003-2007
- An Investigation of the Viatical Settlements Market sponsored by National Institute of Aging, 2003-2007
- Public Policy and Pharmaceutical Innovation Around the World sponsored by Pfizer Incorporated, 2005-2007
Selected Publications
Darius Noshir Lakdawalla et al., "HIV Breakthroughs and Risky Sexual Behavior", Quarterly Journal of Economics, 121(3), 2006
D. Goldman et al., "Consequences of Health Trends and Medical Innovation for the Elderly of the Future", Health Affairs [Web exclusive], 2005
D. Goldman and J. Smith, "Socioeconomic Differences in the Adoption of New Medical Technologies", American Economic Review Papers and Proceedings, 95(2), 2005
D. P. Goldman et al., "Pharmacy Benefits and the Use of Drugs by the Chronically Ill", Journal of the American Medical Association, 291(19), 2004
E. Keeler et al., "Can Medical Savings Accounts for the Nonelderly Reduce Health Care Costs?", Journal of the American Medical Association, 275(21), 1996
Research Focus
Economics of chronic disease, health care reform, health care organization, economics, and finance, pharmaceutical regulation and innovation, pharmacy benefit design
Recent Projects
- Prescription drug benefits
- How new medical treatments affect the chronically ill
Selected Publications
"HIV Breakthroughs and Risky Sexual Behavior," Darius Noshir Lakdawalla et al., Quarterly Journal of Economics, Vol. 121, No. 3, Aug 2006
"Consequences of Health Trends and Medical Innovation for the Elderly of the Future," D. Goldman et al., Health Affairs [Web exclusive], Sept 2005
"Socioeconomic Differences in the Adoption of New Medical Technologies," D. Goldman and J. Smith, American Economic Review Papers and Proceedings, Vol. 95, No. 2, 2005
"Pharmacy Benefits and the Use of Drugs by the Chronically Ill," D. P. Goldman et al., Journal of the American Medical Association, Vol. 291, No. 19, May 2004
"Can Medical Savings Accounts for the Nonelderly Reduce Health Care Costs?" E. Keeler et al., Journal of the American Medical Association, Vol. 275, No. 21, 1996
Recent Media Appearances
Interviews: ABC; Bloomberg News; Boston Globe; CBS; CNN; The Economist; HealthDay.com; NBC; USA Today; Wall Street Journal
Commentary: Los Angeles Times; Press-Enterprise; United Press International
To arrange an interview:
Contact the RAND Office of Media Relations, (703) 413-1100, x5117 or (310) 451-6913, or send an email to media@rand.org.




Top